Bictegravir

Published February 21, 2018; Updated November 05, 2018
Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-07-04
Selected Reference
1. Gallant J, Lazzarin A, Mills A, et al. Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial. Lancet. 2017 Nov 4;390:2063-72.